New Key Statistics Module, Z-Score and F-Score
OTCPK:ARDS Key Ratios
Market Cap $ M | 2.46 |
Enterprise Value $ M | 7.48 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.09 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 19.00 |
EPS (TTM) $ | -0.16 |
Beneish M-Score | 68.57 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.47 |
EV-to-EBITDA | -13.03 |
PEG | -- |
Shares Outstanding M | 44.57 |
Net Margin (%) | -5.81 |
Operating Margin % | -4.49 |
Pre-tax Margin (%) | -5.81 |
Quick Ratio | 0.24 |
Current Ratio | 0.24 |
ROA % (ttm) | -11.59 |
ROE % (ttm) | -- |
ROIC % (ttm) | -4.37 |
Dividend Yield % | -- |
Altman Z-Score | -40.74 |
ARDS Number of Guru Trades
ARDS Volume of Guru Trades
Gurus Latest Trades with OTCPK:ARDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ARDS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aridis Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:ARDS
Total 0- 1